Effect of Passive Heat Therapy on Metabolism
Effect of Repeated Brief Passive Heat Therapy on Metabolism in Healthy Young Adults
1 other identifier
interventional
25
1 country
1
Brief Summary
The goal of this prospective interventional study is to examine if repeated brief hot stimuli affects glucose metabolism and substrate oxidation in young non-obese adults. Young adult participants were asked to participate in fourteen 5-min procedures involving whole body passive heating at 45°C water. The main question it aims to answer is: "Does repeated brief noxious heat stimuli is sufficient to improve glucose tolerance, insulin sensitivity, and fat oxidation in young non-obese adults?"
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Oct 2020
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedFirst Submitted
Initial submission to the registry
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
November 27, 2023
CompletedNovember 27, 2023
November 1, 2023
1.7 years
November 15, 2023
November 17, 2023
Conditions
Outcome Measures
Primary Outcomes (9)
Changes in catecholamines concentration (ng/mL)
The venous plasma adrenaline and noradrenaline concentrations (in ng/mL) were measured using enzyme-linked immunosorbent assay kits and a Spark multimode microplate reader
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Changes in cytokines concentration (pg/mL)
The venous serum interleukin-6 and tumor necrosis factor alpha concentrations (in pg/mL) were measured using enzyme-linked immunosorbent assay kits and a Spark multimode microplate reader
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in glucose concentration (mmol/L)
The venous glucose concentration (in mmol/L) was measured using a Glucocard X-mini plus meter.
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in insulin concentration (μIU/mL)
The venous serum insulin concentrations (in μIU/mL) were measured using enzyme-linked immunosorbent assay kits (Cat. No. E-EL-H2237, Elabscience, China) and a Spark multimode microplate reader (Tecan, Austria).
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in insulin sensitivity
Indices for insulin sensitivity/resistance assessment were computed using the homeostatic model assessment for insulin resistance, quantitative insulin-sensitivity check index (QUICKI), and the Matsuda insulin sensitivity index were calculated.
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in substrate oxidation
Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the respiratory quotient (RQ=VCO2/VO2) was computed to determine substrate utilisation.
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat oxidation (g/min
Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the fat oxidation (FATox; g/min) was calculated by using the equation: FATox = 1.67 × VO2 - 1.67 × VCO2,
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat oxidation (g/min)
Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the carbohydrate oxidation (CARBox; g/min) was calculated by using the equation: CARBox = 4.55 × VCO2 - 3.21 × VO2
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in resting energy expenditure (kcal/day)
Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the resting energy expenditure (REE; kcal/day) was calculated by using the Weir equation: REE = (3.941(VO2) + 1.106(VCO2)) × 1440.
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Secondary Outcomes (7)
Change in body mass (kg)
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat mass (kg)
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat mass (%)
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat free mass (kg)
Pre-condition, post-condition (after 14 days), and after 1 month recovery
Change in fat free mass (%)
Pre-condition, post-condition (after 14 days), and after 1 month recovery
- +2 more secondary outcomes
Study Arms (1)
Heat therapy
EXPERIMENTAL14 heat sessions of whole-body immersed in a 45°C water bath for 5 minutes.
Interventions
14 heat sessions, during each session subjects were fully immersed in a 45°C water bath for 5 minutes.
Eligibility Criteria
You may qualify if:
- healthy non-obese (BMI between 18.5 and 29.9 kg/m2) males and females;
- no diseases, or conditions that could be worsened by exposure to acute hot water and affect experimental variables;
- no participation in any excessive formal physical exercise or sports program, temperature manipulation program or exposure to extreme temperatures.
You may not qualify if:
- smokers;
- obesity (BMI greater than 30 kg/m2);
- needle phobia;
- taking medication and/or dietary supplements that may affect experimental variables.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sport Science and Innovations
Kaunas, Lithuania
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marius Brazaitis, PhD
Lithuanian Sports University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2023
First Posted
November 27, 2023
Study Start
October 1, 2020
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share